ISTH Conference

In this session, Stephan Moll, MD and Taha Bat, MD discuss the latest updates and case discussions from the 2025 International Society on Thrombosis and Haemostasis (ISTH) meeting. They review emerging evidence and guidelines around diagnosis and management of rare coagulopathy (blood clotting) conditions, share clinical cases to illustrate challenges, and suggest approaches to integrate new research into practice.

Key Learning Points:

• New approaches in diagnostics are being emphasized, including more precise assays and biomarkers, to help distinguish rare coagulopathies more reliably and earlier
• Updated treatment options and clinical trials are pushing forward, with more targeted therapies (e.g. novel anticoagulants, replacement factors) being explored for specialized conditions.
• The presenters use real clinical cases to highlight diagnostic dilemmas, therapeutic decision-making, and individualization of care, reinforcing that one size doesn’t fit all.
• +2 more points...